Graphene Turns Twenty and Celebrates by Going Commercial
IDTechEx spoke with HydroGraph (Canada) and learned that the company’s flagship graphene product (FGA-1) has been trialled successfully by Hawkeye Bio in a biomedical sensor aimed at early detection of lung cancer. The sensor detects enzyme activity, as opposed to enzyme quantity in typical sensors, allowing improved detection of inflammatory diseases such as cancer or autoimmunity. It was stated that the “99.8% high purity and consistent geometry” of HydroGraph’s material was crucial to successful trials in the highly sensitive sensors.